Cargando…
His-tag ELISA for the detection of humoral tumor-specific immunity
BACKGROUND: The application of high throughput molecular techniques such as SEREX are resulting in the identification of a multitude of tumor associated antigens. As newly identified antigens are incorporated into a variety of clinical trials, standardization of immunologic monitoring methods become...
Autores principales: | Goodell, Vivian, McNeel, Douglas, Disis, Mary L |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2414992/ https://www.ncbi.nlm.nih.gov/pubmed/18510754 http://dx.doi.org/10.1186/1471-2172-9-23 |
Ejemplares similares
-
ELISA for detection of humoral immunity against measles
por: Zahoor, Muhammad Asif, et al.
Publicado: (2015) -
Pretreatment antigen-specific immunity and regulation - association with subsequent immune response to anti-tumor DNA vaccination
por: Johnson, Laura E., et al.
Publicado: (2017) -
Monitoring Regulatory Immune Responses in Tumor Immunotherapy Clinical Trials
por: Olson, Brian M., et al.
Publicado: (2013) -
Sensitivity and specificity of tritiated thymidine incorporation and ELISPOT assays in identifying antigen specific T cell immune responses
por: Goodell, Vivian, et al.
Publicado: (2007) -
Toll-like receptor agonist combinations augment mouse T-cell anti-tumor immunity via IL-12- and interferon ß-mediated suppression of immune checkpoint receptor expression
por: Jeon, Donghwan, et al.
Publicado: (2022)